Evidence map›Paper›PMID 40792674›Full record

ArticleBiochemistry2025

Functional Proximity across an mRNA.

Breanne M Hatfield, Chase A Weidmann, Christina A McCutchin, Patrick S Irving, Irma M Nelson, Simon Felder, Kevin M Weeks

Abstract read
In one paragraph

Article in Biochemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Breanne M HatfieldDepartment of Chemistry, University of North Carolina, Chapel Hill, North Carolina 27599-3290, United States.
Chase A WeidmannDepartment of Biological Chemistry, Center for RNA Biomedicine, University of Michigan Medical School, Ann Arbor, Michigan 48109, United States.ORCID 0000-0002-2941-0500
Christina A McCutchinDepartment of Chemistry, University of North Carolina, Chapel Hill, North Carolina 27599-3290, United States.ORCID 0009-0006-5455-1395
Patrick S IrvingDepartment of Chemistry, University of North Carolina, Chapel Hill, North Carolina 27599-3290, United States.ORCID 0000-0003-2562-0890
Irma M NelsonDepartment of Chemistry, University of North Carolina, Chapel Hill, North Carolina 27599-3290, United States.
Simon FelderDepartment of Chemistry, University of North Carolina, Chapel Hill, North Carolina 27599-3290, United States.ORCID 0000-0001-5146-5340
Kevin M WeeksDepartment of Chemistry, University of North Carolina, Chapel Hill, North Carolina 27599-3290, United States.ORCID 0000-0002-6748-9985

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Eric R. Fearon · 1988 to 2026
$178.2M
Non-coding RNA structure change in Chronic Obstructive Pulmonary DiseaseR01HL111527 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Alain T Laederach, Kevin M Weeks · 2012 to 2026
$6.6M
Discovery and Function of Higher-Order RNA StructureR35GM122532 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Kevin M Weeks · 2017 to 2026
$5.7M
Unraveling the MALAT1 lncRNA-protein interaction networks that drive lung cancer metastasisK22CA262349 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WEIDMANN, CHASE A · 2021 to 2023
$486k
NCI NIH HHS K22 CA262349NCI NIH HHS P30 CA046592NHLBI NIH HHS R01 HL111527NIGMS NIH HHS R35 GM122532
6 · The paper itself

Abstract

Extensive RNA-protein interactions occur throughout the lifecycle of an mRNA that up- and down-regulate mRNA translation and degradation. Modulating interactions between regulatory proteins and mRNAs can have large effects on gene expression and might be useful for creating therapeutic manipulations, especially for difficult-to-drug proteins. Here, we directed three degradation-inducing proteins that normally bind the 5' cap, 3'-untranslated region (UTR), or 3' poly(A) tail to unconventional sites spanning coding and noncoding regions across a reporter mRNA. DCP2, the 5' decapping enzyme, reduced expression only when targeted to the 5'-UTR. ZFP36L2, a 3'-UTR adapter protein, reduced expression when directed to either the 3'-UTR or the 3' half of the coding sequence, the latter region outside its conventional site. CNOT7, a catalytic subunit within the CCR4-NOT deadenylase complex, reduced expression when directed anywhere in the mRNA, most strongly at both "ends" in the 5'- and 3'-UTRs. mRNAs can therefore be degraded by directing proteins to positions far from their conventionally understood regulatory sites. Our study reveals extensive through-space functional proximity across an mRNA. These observations have broad implications for understanding large-scale RNA structure and for emerging applications in therapeutically targeted RNA degradation.

Indexed as

RNA, Messenger3' Untranslated Regions5' Untranslated RegionsEndoribonucleasesExoribonucleasesHumansRepressor ProteinsRNA-Binding ProteinsRNA StabilityTranscription Factors3' Untranslated Regions5' Untranslated RegionsCNOT7 protein, humanDCP2 protein, humanEndoribonucleasesExoribonucleasesRepressor ProteinsRNA-Binding ProteinsRNA, MessengerTranscription Factors

Identifiers

PMID40792674
PMCPMC12380186

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.